ub ub ub ub ub
ubin the Care of Older Adults, 3rd Edition
ub ub ub ub ub ub ub ub
by Laurie Kennedy-Malone, Verified Chapters 1 - 23, Complete
ub ub ub ub ub ub ub ub
,Answers at the end of the Chapter ub ub ub ub ub ub ub
Chapter 1: Changes withAging ub ub ub ub
Multiple Choice ub
Identify the choice that best completes the statement or answers the question.
ub ub ub ub ub ub ub ub ub ub ub
1. The major impact of the physiological changes that occur with aging is:
ub ub ub ub ub ub ub ub ub ub ub
A. Reduced physiological reserve ub ub
B. Reduced homeostatic mechanisms ub ub
C. Impaired immunological response ub ub
D. All of the above
ub ub ub
2. The strongest evidence regarding normal physiological aging is available through:
ub ub ub ub ub ub ub ub ub
,A. Randomized controlled clinical trials ub ub ub
B. Cross-sectional studies ub
C. Longitudinal studies ub
D. Case control studies ub ub
ub ub 3. All of the following statements are true about laboratory
u b u b ub ub ub ub ub ub ub ub
values in older adultsexcept: ub ub ub
A. Referenceranges are preferable ub ub ub
B. Abnormal findings are often due to physiological aging
ub ub ub ub ub ub ub
C. Normal ranges may not be applicable for older adults
ub ub ub ub ub ub ub ub
D. Reference values are not necessarily acceptable values
ub ub ub ub ub ub
ub ub u b 4. Biochemical individuality is best described as:
u b ub ub ub ub ub
A. Each individual’s variation is often much greater than that of a larger group
ub ub ub ub ub ub ub ub ub ub ub ub
B. The unique biochemical profile of a selected population
ub ub ub ub ub ub ub
C. The truly “normal” individual—falling within average range
ub ub ub ub ub ub
D. Each individual’s variation is often much smaller than that of a larger group
ub ub ub ub ub ub ub ub ub ub ub ub
ub ub u b 5. Polypharmacy is best described as taking:
u b ub ub ub ub ub
A. More than nine medications per day
ub ub ub ub ub
B. More than five medications per day
ub ub ub ub ub
, C. Even a single medication if there is not a clear indication for its use
ub ub ub ub ub ub ub ub ub ub ub ub ub
D. When a drug is given to treat the side effect of another drug
ub ub ub ub ub ub ub ub ub ub ub ub
ub ub u b 6. Pharmacokinetic changes with aging is reflective of:
u b ub ub ub ub ub ub
A. What the drug does to the body
ub ub ub ub ub ub
B. What the body does to the drug
ub ub ub ub ub ub
C. The effect at the site of action and the time and intensity of the drug
ub ub ub ub ub ub ub ub ub ub ub ub ub ub
D. The side effects commonly associated with the drug
ub ub ub ub ub ub ub
ub ub u b 7. All the following statements are false about drug absorption except:
u b ub ub ub ub ub ub ub ub ub
A. Antacids increase the bioavailability of digitalis ub ub ub ub ub
B. Gastric acidity decreases with age ub ub ub ub
C. Anticholinergics increase colonic motility ub ub ub
D. Underlying chronic disease has little impact on drug absorption
ub ub ub ub ub ub ub ub
ub ub 8. All of the following statements are true about drug distribution in the
u b u b ub ub ub ub ub ub ub ub ub ub ub
elderly except: ub
A. Drugs distributed in water have lower concentration
ub ub ub ub ub ub
B. Drugs distributed in fat have less intense, more prolonged effect
ub ub ub ub ub ub ub ub ub
C. Drugs highly protein bound have greater potential to cause an adverse drug reaction
ub ub ub ub ub ub ub ub ub ub ub ub